Cargando…
Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network
Advances in technology have led to a massive expansion in the capacity for genomic analysis, with a commensurate fall in costs. The clinical indications for genomic testing have evolved markedly; the volume of clinical sequencing has increased dramatically; and the range of clinical professionals in...
Autores principales: | Garrett, Alice, Callaway, Alison, Durkie, Miranda, Cubuk, Cankut, Alikian, Mary, Burghel, George J, Robinson, Rachel, Izatt, Louise, Talukdar, Sabrina, Side, Lucy, Cranston, Treena, Palmer-Smith, Sheila, Baralle, Diana, Berry, Ian R, Drummond, James, Wallace, Andrew J, Norbury, Gail, Eccles, Diana M, Ellard, Sian, Lalloo, Fiona, Evans, D Gareth, Woodward, Emma, Tischkowitz, Marc, Hanson, Helen, Turnbull, Clare |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691806/ https://www.ncbi.nlm.nih.gov/pubmed/32170000 http://dx.doi.org/10.1136/jmedgenet-2019-106759 |
Ejemplares similares
-
Combining evidence for and against pathogenicity for variants in cancer susceptibility genes: CanVIG-UK consensus recommendations
por: Garrett, Alice, et al.
Publicado: (2021) -
UK recommendations for SDHA germline genetic testing and surveillance in clinical practice
por: Hanson, Helen, et al.
Publicado: (2023) -
Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variants
por: Loong, Lucy, et al.
Publicado: (2022) -
Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group
por: Taylor, Amy, et al.
Publicado: (2018) -
Developing automated methods for disease subtyping in UK Biobank: an exemplar study on stroke
por: Rannikmäe, Kristiina, et al.
Publicado: (2021)